Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Rowland Charles A Jr
Director at Viking Therapeutics. Filing since 29 May 2018.
CIK 0001383292
Company
Date
Role
Action
Shares
Amount
Of holding
VKTX
Viking Therapeutics, Inc.
27 Oct 2025
Director
Sold at will
60,000
$2.13M
66.7%
VKTX
Viking Therapeutics, Inc.
16 May 2023
Director
Sold at will
40,000
$1.00M
57.1%
VKTX
Viking Therapeutics, Inc.
29 May 2018
Director
Bought
30,000
$154.80K
opened
3 decisions on file.
